Researcher’s Profile

Matthew D. Bacchetta, MD

Surgical Director, Adult Extracorporeal Membrane Oxygenation Program
Director, Pulmonary Thromboendartectomy Program
Surgical Director, The Pulmonary Hypertension Comprehensive Care Center
Body: 

Dr. Matthew Bacchetta is an Associate Professor of Surgery in the Division of Cardio-thoracic Surgery and the Surgical Director of the Pulmonary Hypertension Comprehensive Care Center of CUMC-NYP. He earned his MD from the Weill Medical College of Cornell University where he also did his general surgical training. Following completion of his Thoracic Surgery Fellowship at Columbia, he was appointed to the Thoracic Surgery faculty at NYP/CUMC. He is also the Surgical Director of the Adult Extracorporeal Membrane Oxygenation Program and the Director of the Pulmonary Thromboendarterectomy Program at NYP/CUMC.

Dr. Bacchetta's background in engineering and thoracic surgery has enabled him to become an innovator in the use of mechanical support devices, which can enable patients with pulmonary hypertension to survive through a life-threatening crisis. He is also one of the few skilled surgeons in the US who performs pulmonary thromboendarterectomy for CTEPH (chronic thromboembolic pulmonary hypertension). Under his leadership, the PTE program at CUMC has grown and services patients from around the nation.

Dr. Bacchetta is also a lung transplant surgeon, and he has led efforts at Columbia in bridge to lung transplantation (BTT), which recently reported the best survival in the world for patients who underwent BTT*. He is a Fellow of the American College of Surgeons, a member of the Steering Committee for the Extracorporeal Life Support Organization (ELSO) and the American Society for Artificial Internal Organs (ASAIO). He is an officer in the United States Army Reserves and has served in Iraq and Afghanistan.

Publications: 

Armstrong HF, Lederer DJ, Bacchetta M, Bartels MN. Primary Graft Dysfunction: Long-term physical function outcomes among lung transplant recipients.  Heart & Lung Sept 2016 (Accepted).

Chicotka S, Rosenzweig EB, Brodie D, Bacchetta M.  The “Central Sport Model”: Extracorporeal Membrane Oxygenation Using the Innominate Artery as a Bridge to Lung Transplantation. ASAIO Journal (Accepted).

Agerstrand C, Bacchetta M, Brodie D. Reply to “Differences between veno-venous and Veno-arterial Oxygenation in Pregnancies”. Ann Thorac Surg (Accepted).

Diamond JM, Arcasoy S, McDonnough JA, Sonett JR, Bacchetta M, D'Ovidio F, Cantu E 3rd, Bermudez CA, McBurnie A, Rushefski M, Kalman LH, Oyster M, D'Errico C, Suzuki Y, Giles JT, Ferrante A, Lippel M, Singh G, Lederer DJ, Christie JD; Lung Transplant Body Composition Study. Adipose Gene Expression Profile Changes with Lung Allograft Reperfusion.  Am J Transplantation 2016 (accepted).

Rosenzweig EB, Chicotka S, Bacchetta M. Sequential RVAD Use for Isolated Right Heart Failure due to Pulmonary Arterial Hypertension: Lessons Learned and Future Directions.  J Heart Lung Transplant 2016.  (Accepted).